1. A phase 1b study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors. Issue 9 (14th June 2019) Authors: Weekes, Colin; Lockhart, A. Craig; Lee, James J.; Sturm, Isrid; Cleton, Adriaan; Huang, Funan; Lenz, Heinz‐Josef Journal: International journal of cancer Issue: Volume 145:Issue 9(2019) Page Start: 2450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Exposure–Response Modeling and Simulation of Progression‐Free Survival and Adverse Events of Sorafenib Treatment in Patients With Advanced Thyroid Cancer. Issue 5 (12th April 2019) Authors: Grevel, Joachim; Jentsch, Garrit; Austin, Rupert; Prins, Nicolaas H.; Lettieri, John; Mitchell, David; Huang, Funan; Brose, Marcia S.; Schlumberger, Martin; Meinhardt, Gerold; Peña, Carol E. A.; Ploeger, Bart A. Journal: Clinical and translational science Issue: Volume 12:Issue 5(2019) Page Start: 459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗